Can HDL help with blood sugar?

HDL (high-density lipoprotein) is often called 'good' cholesterol, but its direct role in blood sugar regulation is not firmly established. Observational studies consistently link higher HDL levels with better insulin sensitivity and lower risk of type 2 diabetes. Mechanistically, HDL may protect pancreatic beta cells and reduce inflammation. However, Mendelian randomization studies using genetic variants do not support a causal protective effect on glucose metabolism. Furthermore, drugs that specifically raise HDL (e.g., CETP inhibitors) have failed to show meaningful improvements in glycemic control in clinical trials. Thus, while HDL is a marker of metabolic health, it is unlikely to be a direct therapeutic target for lowering blood sugar. Lifestyle interventions that improve HDL—such as exercise, weight loss, and a Mediterranean diet—also improve glucose metabolism through multiple pathways, making it difficult to isolate HDL's contribution. For individuals with prediabetes or diabetes, the primary focus should remain on LDL cholesterol management and direct glucose-lowering strategies. A normal HDL level is reassuring, but actively trying to raise HDL solely for blood sugar benefits is not evidence-based. Caveat: Evidence is largely observational; causality remains uncertain.